STACIE GUYTON: Open Payments
NPI 1518574490 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 20 payments from 5 companies in 2025. Trend: 2023 $468 · 2024 $544 · 2025 $494
Food & beverage: $314Education: $180
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $216 |
| Janssen Biotech, Inc. | 12 | $172 |
| UCB, Inc. | 3 | $73 |
| Novo Nordisk Inc | 1 | $18 |
| ABBVIE INC. | 1 | $14 |
Products named: DUPIXENT, TREMFYA, Bimzelx, Ozempic, RINVOQ.
Industry payments across DE — which companies pay providers there.
